HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Staunton, M. Articles by Malone, D. E. Search for Related Content PubMed PubMed Citation Articles by Staunton, M. Articles by Malone, D. E.

Finding Evidence-based Answers to Practical Questions in Radiology: Which Patients with Inoperable Hepatocellular Carcinoma Will Survive Longer after Transarterial Chemoembolization?¹

¹ From the Department of Radiology (M.S., J.D.D., D.E.M.) and the Irish National Liver Unit (P.A.M.), St Vincent's University Hospital, Elm Park, Dublin 4, Ireland; and Department of Radiology, Hamilton Health Sciences Corp, McMaster University Medical Centre, Hamilton, Ontario, Canada (M.S.). Received January 10, 2004; revision requested March 11; revision received September 27; accepted October 20. Address correspondence to D.E.M. (e-mail: D.Malone{at}st-vincents.ie).

View larger version (27K): [in a new window]   Meta-analysis of RCTs for analysis of 2-year patient survivals after chemoembolization and/or embolization as compared with 2-year patient survivals after conservative management or suboptimal therapies for unresectable HCC. In the random effects model, the odds ratio was 0.53 (95% CI: 0.32, 0.89; P < .017). (Reprinted, with permission, from reference 18.)